These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 9229830
1. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis]. Pospekhova GP, Kaiukov IG, Sinitsina TM, Razorenova TS. Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830 [No Abstract] [Full Text] [Related]
2. [Kombipek in the therapy of patients with broncho-obstructive lung diseases]. Chuchalin AG, Tsoĭ AN, Zaĭtseva TM, Titova EV, Medani SM, Smirnov MV, Kaziakhmedov EA. Ter Arkh; 1995; 67(6):26-9. PubMed ID: 7667774 [Abstract] [Full Text] [Related]
3. [Broncholytic effect of Atrovent in comparison with a combination preparation in obstructive lung diseases]. Holzhey P. Wien Med Wochenschr; 1975 Dec 05; 125(49):711-6. PubMed ID: 1229127 [No Abstract] [Full Text] [Related]
5. [The grade of dyspnea in patients treated with a theophylline derivative (bamifylline) vs controlled-absorption theophylline]. Giosuè S, Parola D, Cafaggi R, Astengo D, Greco G, D'Onofrio V. Clin Ter; 1987 Dec 31; 123(6):457-63. PubMed ID: 2972503 [No Abstract] [Full Text] [Related]
6. [Theophylline and selective phosphodiesterase inhibitor in therapy of obstructive respiratory tract diseases]. Rabe KF, Dent G, Magnussen H. Pneumologie; 1997 Mar 31; 51(3):303-16. PubMed ID: 9173421 [No Abstract] [Full Text] [Related]
7. [Current broncholytic and expectorant therapy of patients with chronic nonspecific lung diseases]. Solopov VN, Kolganova NA, Chuchalin AG. Ter Arkh; 1987 Mar 31; 59(12):96-9. PubMed ID: 2965833 [Abstract] [Full Text] [Related]
8. Theophylline in the treatment of the elderly with chronic obstructive pulmonary disease. Antognozzi G, Buzzo P, Mori M, Ellena S, Triolo A. Riv Eur Sci Med Farmacol; 1994 Mar 31; 16(3-4):69-72. PubMed ID: 7480962 [Abstract] [Full Text] [Related]
9. [Therapeutic action of a new xanthine derivative in respiratory pathology]. Cesco G, Biondi T, Mazzini R. Clin Ter; 1986 Aug 31; 118(4):253-7. PubMed ID: 3530620 [No Abstract] [Full Text] [Related]
12. [A strategy of drug treatment of obstructive respiratory tract diseases]. Slapke J, Adolph J. Z Arztl Fortbild (Jena); 1989 Mar 30; 83(17):857-9. PubMed ID: 2686213 [No Abstract] [Full Text] [Related]
13. [The hemodynamic effects of reproterol in patients with chronic obstructive lung disease (author's transl)]. Bonaduce D, Ferrara N, Canonico V, Cocozza M, Petretta M, Romano E, Rengo F. G Ital Cardiol; 1981 Mar 30; 11(10):1467-71. PubMed ID: 7341317 [Abstract] [Full Text] [Related]
16. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases]. Salikova VV, Nonikov VE, Belousov IuB. Ter Arkh; 1993 Mar 30; 65(8):41-4. PubMed ID: 8211801 [Abstract] [Full Text] [Related]
19. [Correlative aspects of spirographic, oximetric and zonal ventilation-perfusion ratio findings in chronic obstructive bronchopneumopathy. I. Some comparative oximetric and ventilatory data in evaluation of the effectiveness of bronchodilator treatment]. Fica V, Stănescu L, Olteanu D, Mătrescu F, Andronescu D, Ionescu A. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977 Mar 30; 29(2):149-56. PubMed ID: 17907 [No Abstract] [Full Text] [Related]
20. [Evaluation of ventilation changes in patients with obstructive bronchopneumopathy induced by bronchodilator drugs]. De Benedetto F, Cervone M, De Blasio E, D'Ilario F, Fuciarelli R, Luciano A, Sborgia M. Clin Ter; 1984 Jun 30; 109(6):509-17. PubMed ID: 6236941 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]